Cabometyx and Hyperthyroidism aggravated - a phase IV clinical study of FDA data

Summary:

Hyperthyroidism aggravated is reported as a side effect among people who take Cabometyx (cabozantinib s-malate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Opdivo, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Hyperthyroidism aggravated when taking Cabometyx. It is created by eHealthMe based on reports of 35,066 people who have side effects when taking Cabometyx from the FDA, and is updated regularly.

What is Cabometyx?

Cabometyx has active ingredients of cabozantinib s-malate. eHealthMe is studying from 35,069 Cabometyx users. Check the latest studies of Cabometyx.

What is Hyperthyroidism aggravated?

Hyperthyroidism aggravated (over activity of the thyroid gland) is found to be associated with 882 drugs and 362 conditions by eHealthMe. Check the latest studies of Hyperthyroidism aggravated.

On Jul, 21, 2026

35,066 people reported to have side effects when taking Cabometyx.
Among them, 117 people (0.33%) have Hyperthyroidism aggravated.

Could Cabometyx cause Hyperthyroidism aggravated?

Among these 117 people:

How long have people been on Cabometyx when they have Hyperthyroidism aggravated? *

Click here to view more results

What is the gender of people who have Hyperthyroidism aggravated when taking Cabometyx? *

Click here to view

What is the age of people who have Hyperthyroidism aggravated when taking Cabometyx? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Cabometyx and have Hyperthyroidism aggravated?

- Check whether Hyperthyroidism aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cabometyx:

Cabometyx (35,069 reports)

Hyperthyroidism aggravated treatments and more:

Hyperthyroidism aggravated (29 reports)

How severe was Hyperthyroidism aggravated and when was it recovered:

Hyperthyroidism aggravated in Cabometyx

Expand to all the drugs that have ingredients of cabozantinib s-malate:

Hyperthyroidism aggravated and drugs with ingredients of cabozantinib s-malate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cabometyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (882 drugs)

Browse all the conditions that are associated with Hyperthyroidism aggravated:

Hyperthyroidism aggravated (362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cabozantinib s-malate (the active ingredients of Cabometyx) and Cabometyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.